Table of Contents

• R C Eastman and
• F Vinicor

Science: moving us in the right direction.

• M W Steffes

Diabetic nephropathy: incidence, prevalence, and treatment.

• W D Lougheed,
• B Zinman,
• T R Strack,
• L J Janis,
• A B Weymouth,
• E A Bernstein,
• A M Korbas,
• and B H Frank

Stability of insulin lispro in insulin infusion systems.

• B R Vohr and
• S T McGarvey

Growth patterns of large-for-gestational-age and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year.

• E N Lazaridis,
• C Qiu,
• S K Kraft,
• and D G Marrero

Same eyes, different doctors: differences in primary care physician referrals for diabetic retinopathy screening.

Diabetes nutrition and complications trial (DNCT): food intake and targets of diabetes treatment in a sample of Spanish people with diabetes. Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu).

• J Tuomilehto,
• K Borch-Johnsen,
• A Molarius,
• V Jormanainen,
• R Lounamaa,
• C Grönhagen-Riska,
• A Reunanen,
• and C Sarti

The unchanging incidence of hospitalization for diabetic nephropathy in a population-based cohort of IDDM patients in Finland.

• S M Haffner,
• H Miettinen,
• and M P Stern

The homeostasis model in the San Antonio Heart Study.

• J S Yudkin,
• A E Denver,
• V Mohamed-Ali,
• K L Ramaiya,
• D K Nagi,
• S Goubet,
• D G McLarty,
• and A Swai

The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. A study of two ethnic groups.

• A A Motala,
• M A Omar,
• and E Gouws

Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

• J B Ruige,
• M R Batstra,
• H J Aanstoot,
• L M Bouter,
• G J Bruining,
• J N De Neeling,
• and R J Heine

Low prevalence of antibodies to GAD65 in a 50- to 74-year-old general Dutch population. The Hoorn Study.

• J E Aikens and
• R Mayes

Elevated glycosylated albumin in NIDDM is a function of recent everyday environmental stress.

• Z Trajanoski,
• G A Brunner,
• L Schaupp,
• M Ellmerer,
• P Wach,
• T R Pieber,
• P Kotanko,
• and F Skrabal

Open-flow microperfusion of subcutaneous adipose tissue for on-line continuous ex vivo measurement of glucose concentration.

• C C Chow,
• G T Ko,
• L W Tsang,
• V T Yeung,
• J C Chan,
• and C S Cockram

Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.

• S G Dorsey,
• C F Waltz,
• L Brosch,
• I Connerney,
• E J Schweitzer,
• and S T Bartlett

A neural network model for predicting pancreas transplant graft outcome.

• M Ishii,
• T Nakamura,
• F Kasai,
• T Baba,
• and K Takebe

Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.

• Y Suzuki,
• S Suzuki,
• Y Hinokio,
• M Chiba,
• Y Atsumi,
• K Hosokawa,
• A Shimada,
• T Asahina,
• and K Matsuoka

Diabetes associated with a novel 3264 mitochondrial tRNA(Leu)(UUR) mutation.

• K L Jones,
• M Horowitz,
• M Berry,
• J M Wishart,
• and S Guha

Blood glucose concentration influences postprandial fullness in IDDM.

• C Trautner,
• A Icks,
• B Haastert,
• F Plum,
• and M Berger

Incidence of blindness in relation to diabetes. A population-based study.

• C Allen,
• G Shen,
• M Palta,
• B Lotz,
• R Jacobson,
• and D D'Alessio

Long-term hyperglycemia is related to peripheral nerve changes at a diabetes duration of 4 years. The Wisconsin Diabetes Registry.

• K Yamada,
• X Yuan,
• S Ishiyama,
• F Ichikawa,
• K I Koyama,
• A Koyanagi,
• W Koyama,
• and K Nonaka

Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.

• A I Adler,
• E J Boyko,
• J H Ahroni,
• V Stensel,
• R C Forsberg,
• and D G Smith

Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.

• E Korpinen,
• P H Groop,
• H K Akerblom,
• and O Vaarala

Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease.

• M Balsells,
• R Corcoy,
• D Mauricio,
• J Morales,
• A García-Patterson,
• G Carreras,
• M Puig-Domingo,
• and A de Leiva

Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes.

• D O Clark

Physical activity efficacy and effectiveness among older adults and minorities.

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

• Z T Bloomgarden

The 32nd Annual Meeting of the European Association for the Study of Diabetes. Macrovascular disease.

• C T Bau,
• W H Sheu,
• Y M Song,
• L N Tseng,
• and C C Wang

Acanthosis nigricans and diabetic ketoacidosis.

• M E Griffin,
• T Fulcher,
• K Nikookam,
• J Crowley,
• R G Firth,
• and N M O'Meara

Down's syndrome, IDDM, and hypothyroidism.

• V Bril,
• J Kojic,
• and R Chun

Does severity of neuropathy influence consent to invasive investigative procedures in clinical trials? Determinants for sural nerve biopsy.

• F R Velazquez

Evaluation of blood glucose meters during hypoglycemia.

• D R Parker and
• I A Ismail

Accuracy of blood glucose meters during hypoglycemia.

• E Chantelau

Hyperbaric oxygen therapy for diabetic foot ulcers.

• F Sternberg,
• U Hoss,
• M Salgado,
• and E F Pfeiffer

Self-monitoring of blood glucose compared with continuous tissue glucose measurement.

• R S Crausman,
• J Wen,
• and S Al-Shalabi

Choreoathetosis and diabetes.

• M Odawara,
• C Bannai,
• T Saitoh,
• Y Kawakami,
• and K Yamashita

Potentially lethal ileus associated with acarbose treatment for NIDDM.

• J Karsegard,
• J Wicky,
• N Mensi,
• A Caulfield,
• and J Philippe

Spurious glycohemoglobin values associated with hydroxyurea treatment.

• P L Selvais,
• M P Hermans,
• J E Donckier,
• and M Buysschaert

Reported rates, incentives, and effectiveness of major vaccinations in 501 attendees at two diabetes clinics.

• F Ziel

Bloomgarden's February editorial on managed care.

• M W Strachan and
• B M Frier

Early postprandial hypoglycemia following administration of lispro insulin.

• C Petrogiannopoulos and
• A Zacharof

Glibenclamide and liver disease.